As global markets grapple with heightened geopolitical tensions and inflationary pressures, investors are navigating a complex landscape marked by fluctuating oil prices and rising Treasury yields. Amidst this volatility, identifying stocks trading below their estimated worth can present an opportunity for those looking to capitalize on potential value in the market.
Top 10 Undervalued Stocks Based On Cash Flows
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Wacom (TSE:6727) | ¥822.00 | ¥1601.48 | 48.7% |
| Thai Vegetable Oil (SET:TVO) | THB26.75 | THB51.97 | 48.5% |
| Sulzer (SWX:SUN) | CHF147.10 | CHF287.24 | 48.8% |
| P.S.P. Specialties (SET:PSP) | THB7.65 | THB14.80 | 48.3% |
| Nickel Asia (PSE:NIKL) | ₱4.45 | ₱8.61 | 48.3% |
| Dongwon Industries (KOSE:A006040) | ₩36600.00 | ₩71811.24 | 49% |
| Boliden (OM:BOL) | SEK525.60 | SEK1013.21 | 48.1% |
| Apator (WSE:APT) | PLN25.15 | PLN48.85 | 48.5% |
| AK Medical Holdings (SEHK:1789) | HK$4.91 | HK$9.60 | 48.9% |
| 3SBio (SEHK:1530) | HK$16.22 | HK$32.25 | 49.7% |
Click here to see the full list of 108 stocks from our Undervalued Global Stocks Based On Cash Flows screener.
Let’s explore several standout options from the results in the screener.
Astellas Pharma (TSE:4503)
Overview: Astellas Pharma Inc. is a global pharmaceutical company involved in the research, development, manufacture, sale, and supply of pharmaceuticals with a market cap of ¥4.11 trillion.
Operations: The company’s revenue is primarily derived from its pharmaceutical segment, totaling ¥2.27 trillion.
Estimated Discount To Fair Value: 41.1%
Astellas Pharma is trading at a significant discount to its estimated fair value, with shares priced ¥2,326.5 against a future cash flow valuation of ¥3,950.7. Despite this undervaluation and recent profit growth, the company’s earnings and revenue are projected to decline over the next three years. Astellas maintains a reliable dividend yield of 3.44% and continues to invest in innovative treatments like ASP2138 for gastric cancer while engaging in strategic agreements to enhance patient access and affordability in healthcare markets.
- The growth report we’ve compiled suggests that Astellas Pharma’s future prospects could be on the up.
- Click here to discover the nuances of Astellas Pharma with our detailed financial health report.
Canon (TSE:7751)
Overview: Canon Inc., along with its subsidiaries, operates in the development, production, sale, and servicing of printing, medical, imaging, and industrial equipment across Japan, the Americas, Europe, Asia, and Oceania with a market cap of approximately ¥3.78 trillion.
Operations: Canon’s revenue is derived from its diverse operations in printing, medical, imaging, and industrial equipment across multiple regions including Japan, the Americas, Europe, Asia, and Oceania.
Estimated Discount To Fair Value: 36.5%
Canon is trading at a notable discount to its estimated future cash flow value, with shares priced at ¥4,431 compared to a valuation of ¥6,978.25. Despite this undervaluation and recent earnings growth of 109.1%, Canon’s forecasted annual profit and revenue growth rates are below the market average in Japan. The company recently completed a significant share buyback program valued at approximately ¥200 billion, which may support shareholder value in the short term.
- Our earnings growth report unveils the potential for significant increases in Canon’s future results.
- Click to explore a detailed breakdown of our findings in Canon’s balance sheet health report.
Ricoh Company (TSE:7752)
Overview: Ricoh Company, Ltd. operates in digital services, digital products, graphic communications, and industrial solutions across Japan and globally with a market cap of ¥917.83 billion.
Operations: The company’s revenue is derived from its operations in digital services, digital products, graphic communications, and industrial solutions across various regions including Japan, the Americas, Europe, the Middle East, and Africa.
Ricoh Company is trading at ¥1,619.5, significantly below its estimated future cash flow value of ¥2,561.46, indicating it is undervalued based on cash flows. Despite this valuation gap and a 74.7% earnings growth over the past year, Ricoh’s earnings are forecasted to decline by 1.8% annually over the next three years. The company has completed a share buyback worth ¥6.45 billion but faces challenges with slower revenue growth compared to the market average in Japan.
- In light of our recent growth report, it seems possible that Ricoh Company’s financial performance will exceed current levels.
- Take a closer look at Ricoh Company’s balance sheet health here in our report.
Make It Happen
- Click here to access our complete index of 108 Undervalued Global Stocks Based On Cash Flows.
- Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St’s portfolio, where intuitive tools await to help optimize your investment outcomes.
- Simply Wall St is a revolutionary app designed for long-term stock investors, it’s free and covers every market in the world.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven’t yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New:AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com
Three rival AI bosses just backed slowing AI down for safety. But who would a slowdown actually protect?
Millions of jobs. That would get protected for a bit.
If AI gets regulated in the US, it will be China that wins.
It’s Pandora’s box. It will advance with or without US frontier labs.
Are social media stocks the new Big Tobacco?
Greater regulatory scrutiny is catching up with digital platforms, posing a rising risk for social media stocks. But as Big Tobacco discovered, that’s not always a bad outcome for shareholders.
14
Sep 11, 2026
About TSE:7752
Ricoh Company
Engages in the digital services, digital products, graphic communications, industrial solutions, and other businesses in Japan, the Americas, Europe, the Middle East, Africa, and internationally.
Undervalued with solid track record and pays a dividend.
Similar Companies
Market Insights
Are social media stocks the new Big Tobacco?AN
Andrew Legget
What 13F filings won’t tell you about a billionaire’s stock picksMI
Mitchell Lawler
Great earnings season, but are the earnings real?AN
Andrew Legget
Advertisement
Weekly Picks
Ceazaron Sparc AI·19 days ago
When GPS fails: this small cap is fixing a $54B drone problem
Fair Value:CA$5.2539.8% undervalued
193followersusers have followed this narrative
·0commentsusers have commented on this narrative
·29likesusers have liked this narrative
WE
WealthAPon Copart·2 months ago
Copart’s Share Price Fell. Its Moat Did Not.
Fair Value:US$4935.2% undervalued
42followersusers have followed this narrative
·2commentsusers have commented on this narrative
·13likesusers have liked this narrative
IV
Ivoedon ASML Holding·about 1 month ago
ASML’s China Sell-Off Looks Overdone, Yet The Shares Are Not Cheap
FundamentalContrarianInvestoron Universal Music Group·22 days ago
Universal Music Group: The Market Is Pricing the Quarter, Not the Catalogue
RecentlyUpdated Narratives
RockeTelleron Honey Badger Silver·about 2 hours ago
Honey Badger: 766g/t AgEq, 5km of Tunnels, Mill Already There, Why September’s PEA Matters
woodworthfundon Willamette Valley Vineyards·about 14 hours ago
Willamette Valley Vineyards (WVVI): Not-So-Great Value
Fair Value:US$0.2850.0% overvalued
14followersusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
BRBrunhilde_Wagneron Copart·about 15 hours ago
Compounder to Cash Generator in Real Time
Popular Narratives
AnalystConsensusTargeton NVIDIA·about 2 months ago
NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
AnalystConsensusTargeton Alphabet·4 months ago
GOOGL: AI Platform Expansion And Cloud Demand Will Support Durable Performance Amid Competitive Pressures
AnalystConsensusTargeton Amazon.com·about 1 month ago
